August 2018
Core topics in this month’s edition include:
- Oxervate (cenegermin-bkbj) - new orphan drug approval
- Onpattro (patisiran) - new orphan drug approval
- Orkambi (lumacaftor/ivacaftor) - expanded indication, new formulation approval
- valsartan, valsartan/hydrochlorothiazide (HCTZ), and amlodipine/valsartan/HCTZ tablets - drug recall
Top